Rank: 47 (Previous rank: 39)
Compare tool: Pfizer vs. Top 10
CEO: Jeffrey B. Kindler
Address: 235 E. 42nd St.
New York, NY 10017
Phone: 212-573-2323
Website: www.pfizer.com
Slowing R&D has caused Pfizer's pipeline to run dry. It also lost patents on some of its best-selling drugs, including the blood pressure med Norvasc and the antidepressant Zoloft, and now faces competition from new generic versions. The pharma's anti-smoking drug Chantix, which some users claim induces suicidal thoughts and depression, caused a public relations headache. For the year, revenue fell 7.6%. The sale of its OTC division to Johnson & Johnson in 2006 caused 2007 earnings to drop 58%, despite a boost from high-priced medications in international markets.
|
Revenues |
48,418.0 |
-7.6 |
Profits |
8,144.0 |
-57.9 |
Assets |
115,268.0 |
— |
Stockholders' equity |
65,010.0 |
— |
Market value (3/28/2008) |
138,655.2 |
— |
Revenues |
16.8 |
Assets |
7.1 |
Stockholders' equity |
12.5 |
2007 $ |
1.17 |
% change from 2006 |
-56.0 |
1997-2007 annual growth rate % |
7.5 |
2007 |
-8.1 |
1997-2007 annual rate |
1.2 |
4 | Merck | 101 | 24,197.7 | 5 | Wyeth | 113 | 22,399.8 | 6 | Bristol-Myers Squibb | 125 | 19,977.0 | 7 | Eli Lilly | 133 | 18,633.5 | 8 | Amgen | 173 | 14,771.0 | 9 | Schering-Plough | 212 | 12,690.0 | 10 | Gilead Sciences | 536 | 4,230.0 | 11 | Allergan | 554 | 3,958.9 | 12 | Genzyme | 572 | 3,813.5 | 13 | Forest Laboratories | 605 | 3,441.8 | 14 | Hospira | 608 | 3,436.2 | 15 | Biogen Idec | 648 | 3,171.6 | 16 | Mylan | 736 | 2,666.0 | 17 | Barr Pharmaceuticals | 760 | 2,557.6 | 18 | Watson Pharmaceuticals | 775 | 2,496.7 | 19 | King Pharmaceuticals | 857 | 2,136.5 | 20 | NBTY | 894 | 2,014.5 | 21 | Cephalon | 952 | 1,772.6 |
From the May 5, 2008 issue
|
|
See Pfizer in...
...Featured Companies
(1 of 1)
|